Metabolomics analysis reveals an effect of homocysteine on arachidonic acid and linoleic acid metabolism pathway

Li,Bin; Gao,Guangqiang; Zhang,Wanying; Li,Bowen; Yang,Chun; Jiang,Xiaofeng; Tian,Yaping; Liang,Hongyan

doi:10.3892/mmr.2018.8643

Metabolomics analysis reveals an effect of homocysteine on arachidonic acid and linoleic acid metabolism pathway

Authors:
- Bin Li
- Guangqiang Gao
- Wanying Zhang
- Bowen Li
- Chun Yang
- Xiaofeng Jiang
- Yaping Tian
- Hongyan Liang
View Affiliations

Affiliations: Department of Clinical Laboratory, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Clinical Biochemistry, Chinese PLA General Hospital, Beijing 100853, P.R. China
Published online on: February 27, 2018 https://doi.org/10.3892/mmr.2018.8643
Pages: 6261-6268
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An increase in serum homocysteine level has been associated with an increased risk of vascular disease; however, the biochemical mechanisms that underlie these effects remain largely unknown. The present study aimed to use high-performance liquid chromatography-mass spectrometry (HPLC‑MS) to demonstrate the effects of serum homocysteine on human blood metabolites. A total of 75 fasting serum samples were investigated in the present study. Using a threshold of 15 µmol/l serum homocysteine level, samples were divided into high‑ and low‑homocysteine groups, and the serum extracts were analyzed with an HPLC‑MS‑based method. A total of 269 features exhibited significant differences and correlation with serum homocysteine levels in the electrospray ionization‑positive [ESI(+)] mode, and 69 features were identified in the ESI(‑) mode between the two groups. The principal component analysis plot revealed a separation between the high‑ and the low‑homocysteine groups. Metabolite set enrichment analysis identified arachidonic acid metabolism and linoleic acid metabolism as the two pathways with significantly enriched differences. These results revealed that arachidonic acid and linoleic acid metabolism may be associated with serum homocysteine levels and may be involved in homocysteine-induced vascular disease.

View Figures

View References

1	McCully KS: Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol. 56:111–128. 1969.PubMed/NCBI
2	Moll S: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 337:1631–1632; author reply 1632–1633. 1997. View Article : Google Scholar : PubMed/NCBI
3	Soinio M, Marniemi J, Laakso M, Lehto S and Rönnemaa T: Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med. 140:94–100. 2004. View Article : Google Scholar : PubMed/NCBI
4	Arnesen E, Refsum H, Bønaa KH, Ueland PM, Førde OH and Nordrehaug JE: Serum total homocysteine and coronary heart disease. Int J Epidemiol. 24:704–709. 1995. View Article : Google Scholar : PubMed/NCBI
5	Cheng SW, Ting AC and Wong J: Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Ann Vasc Surg. 11:217–223. 1997. View Article : Google Scholar : PubMed/NCBI
6	Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, et al: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 277:1775–1781. 1997. View Article : Google Scholar : PubMed/NCBI
7	Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM and Shaper AG: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet. 346:1395–1398. 1995. View Article : Google Scholar : PubMed/NCBI
8	Towfighi A, Saver JL, Engelhardt R and Ovbiagele B: Factors associated with the steep increase in late-midlife stroke occurrence among US men. J Stroke Cerebrovasc Dis. 17:165–168. 2008. View Article : Google Scholar : PubMed/NCBI
9	Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA. 288:2015–2022. 2002. View Article : Google Scholar : PubMed/NCBI
10	Boushey CJ, Beresford SA, Omenn GS and Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 274:1049–1057. 1995. View Article : Google Scholar : PubMed/NCBI
11	Selhub J: Homocysteine metabolism. Annu Rev Nutr. 19:217–246. 1999. View Article : Google Scholar : PubMed/NCBI
12	McCully KS: Homocysteine and the pathogenesis of atherosclerosis. Expert Rev Clin Pharmacol. 8:211–219. 2015. View Article : Google Scholar : PubMed/NCBI
13	Nicholson JK, Lindon JC and Holmes E: ‘Metabonomics’: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 29:1181–1189. 1999. View Article : Google Scholar : PubMed/NCBI
14	Wikoff WR, Gangoiti JA, Barshop BA and Siuzdak G: Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem. 53:2169–2176. 2007. View Article : Google Scholar : PubMed/NCBI
15	Xue R, Lin Z, Deng C, Dong L, Liu T, Wang J and Shen X: A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 22:3061–3068. 2008. View Article : Google Scholar : PubMed/NCBI
16	Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, Bressman SS and Flint Beal M: Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain. 131:389–396. 2008. View Article : Google Scholar : PubMed/NCBI
17	Nicholson JK, Connelly J, Lindon JC and Holmes E: Metabonomics: A platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 1:153–161. 2002. View Article : Google Scholar : PubMed/NCBI
18	Want EJ, Nordström A, Morita H and Siuzdak G: From exogenous to endogenous: The inevitable imprint of mass spectrometry in metabolomics. J Proteome Res. 6:459–468. 2007. View Article : Google Scholar : PubMed/NCBI
19	Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults, . Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 35:390–419. 2007.(In Chinese). PubMed/NCBI
20	Chen C and Lu FC: Department of Disease Control Ministry of Health, PR China: The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 17 Suppl:S1–S36. 2004.
21	Guo H, Chi J, Xing Y and Wang P: Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina. Indian J Med Res. 129:279–284. 2009.PubMed/NCBI
22	Xu J, Tian YP, Chen YH, Zhang RP, Yang F, Song YM and Zeper A: Plasma preparation method for metabollomic analysis based on rapid resolution liquid chromatography-mass spectrometry. Chin J Anal Chem. 39:1793–1797. 2011. View Article : Google Scholar
23	Smith CA, Want EJ, O'Maille G, Abagyan R and Siuzdak G: XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 78:779–787. 2006. View Article : Google Scholar : PubMed/NCBI
24	Xia J, Mandal R, Sinelnikov IV, Broadhurst D and Wishart DS: MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res. 40:(Web Server Issue). W127–W133. 2012. View Article : Google Scholar : PubMed/NCBI
25	Xia J, Sinelnikov IV, Han B and Wishart DS: MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic Acids Res. 43(W1): W251–W257. 2015. View Article : Google Scholar : PubMed/NCBI
26	Xia J and Wishart DS: MetPA: A web-based metabolomics tool for pathway analysis and visualization. Bioinformatics. 26:2342–2344. 2010. View Article : Google Scholar : PubMed/NCBI
27	Xue SS, He JL, Zhang X, Liu YJ, Xue FX, Wang CJ, Ai D and Zhu Y: Metabolomic analysis revealed the role of DNA methylation in the balance of arachidonic acid metabolism and endothelial activation. Biochim Biophys Acta. 1851:1317–1326. 2015. View Article : Google Scholar : PubMed/NCBI
28	Capdevila JH, Falck JR and Harris RC: Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res. 41:163–181. 2000.PubMed/NCBI
29	Wang Y, Wei X, Xiao X, Hui R, Card JW, Carey MA, Wang DW and Zeldin DC: Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. J Pharmacol Exp Ther. 314:522–532. 2005. View Article : Google Scholar : PubMed/NCBI
30	Xiao B, Li X, Yan J, Yu X, Yang G, Xiao X, Voltz JW, Zeldin DC and Wang DW: Overexpression of cytochrome P450 epoxygenases prevents development of hypertension in spontaneously hypertensive rats by enhancing atrial natriuretic peptide. J Pharmacol Exp Ther. 334:784–794. 2010. View Article : Google Scholar : PubMed/NCBI
31	Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ and Mittendorfer B: Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperaminoacidemia-hyperinsulinemiain healthy young and middle-aged men and women. Clin Sci (Lond). 121:267–278. 2011. View Article : Google Scholar : PubMed/NCBI
32	Imig JD and Hammock BD: Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 8:794–805. 2009. View Article : Google Scholar : PubMed/NCBI
33	Nishimura M, Hirai A, Omura M, Tamura Y and Yoshida S: Arachidonic acid metabolites by cytochrome P-450 dependent monooxygenase pathway in bovine adrenal fasciculata cells. Prostaglandins. 38:413–430. 1989. View Article : Google Scholar : PubMed/NCBI
34	Capdevila J, Marnett LJ, Chacos N, Prough RA and Estabrook RW: Cytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyicosatetraenoic acids. Proc Natl Acad Sci USA. 79:pp. 767–770. 1982; View Article : Google Scholar : PubMed/NCBI
35	Ma C, Wang Y, Shen T, Zhang C, Ma J, Zhang L, Liu F and Zhu D: Placenta growth factor mediates angiogenesis in hypoxic pulmonary hypertension. Prostaglandins Leukot Essent Fatty Acids. 89:159–168. 2013. View Article : Google Scholar : PubMed/NCBI
36	Blazevic T, Schwaiberger AV, Schreiner CE, Schachner D, Schaible AM, Grojer CS, Atanasov AG, Werz O, Dirsch VM and Heiss EH: 12/15-lipoxygenase contributes to platelet-derived growth factor-induced activation of signal transducer and activator of transcription 3. J Biol Chem. 288:35592–35603. 2013. View Article : Google Scholar : PubMed/NCBI
37	Bellien J and Joannides R: Epoxyeicosatrienoic acid pathway in human health and diseases. J Cardiovasc Pharmacol. 61:188–196. 2013. View Article : Google Scholar : PubMed/NCBI